Published in Henry Ford Hosp Med J on January 01, 1987
Experience in the surgical management of medullary thyroid carcinoma. Ann R Coll Surg Engl (1991) 0.75
Calcitonin gene-related peptide is a potent vasodilator. Nature (1985) 6.13
The local repressor AcrR plays a modulating role in the regulation of acrAB genes of Escherichia coli by global stress signals. Mol Microbiol (1996) 4.56
Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int (1999) 3.09
Effects of internal divalent cations on voltage-clamped squid axons. J Gen Physiol (1974) 2.94
Hyperleptinaemia in chronic heart failure. Relationships with insulin. Eur Heart J (1998) 2.73
Differences in proximal femur bone density over two centuries. Lancet (1993) 2.51
A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med (1998) 2.42
Bone-density measurement. Lancet (1992) 2.38
Human calcitonin in the treatment of Paget's bone disease. Lancet (1971) 2.37
Body fat distribution, rather than overall adiposity, influences serum lipids and lipoproteins in healthy men independently of age. Am J Med (1995) 2.31
Plasma-immunoreactive-calcitonin in patients with non-thyroid tumours. Lancet (1974) 2.30
Sex- and menopause-associated changes in body-fat distribution. Am J Clin Nutr (1992) 2.23
Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol (1997) 2.19
Female multiple mating behaviour in the common shrew as a strategy to reduce inbreeding. Proc Biol Sci (1993) 2.19
THE DISTRIBUTION OF INFLUENZA BY DIRECT CONTACT-HANDS AND EATING UTENSILS. Am J Public Health (N Y) (1919) 2.05
Isolation and characterization of human calcitonin gene-related peptide. Nature (1984) 2.03
Insulin resistance and cigarette smoking. Lancet (1992) 1.98
Affinity of calciferol analogues for 25-hydroxycholecalciferol receptors. Clin Sci Mol Med (1974) 1.83
Rifampicin and vitamin D metabolism. Clin Pharmacol Ther (1980) 1.78
The TASK-1 two-pore domain K+ channel is a molecular substrate for neuronal effects of inhalation anesthetics. J Neurosci (2000) 1.77
Postmenopausal osteoporosis. Br Med J (Clin Res Ed) (1983) 1.77
Epilepsy and employment. Community Health (Bristol) (1976) 1.75
Effects of propofol and thiopental in isolated rat aorta and pulmonary artery. Anesthesiology (1992) 1.71
Calcitonin for prevention of postmenopausal bone loss. Lancet (1988) 1.71
PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis. Kidney Int (2001) 1.69
Insulin resistance: syndrome or tendency? Lancet (1995) 1.69
Potent vasodilator activity of calcitonin gene-related peptide in human skin. J Invest Dermatol (1986) 1.68
Magnesium exchange between blood and cerebrospinal fluid. Am J Physiol (1963) 1.67
Effect of thyrocalcitonin in man. Lancet (1966) 1.67
Molybdate metabolism in Aspergillus nidulans. I. Mutations affecting nitrate reductase and-or xanthine dehydrogenase. Mol Gen Genet (1970) 1.67
Co-localization of calcitonin gene-related peptide-like immunoreactivity with substance P in cutaneous, vascular and visceral sensory neurons of guinea pigs. Neurosci Lett (1985) 1.66
Bombesin: action on gut hormones and calcium in man. J Clin Endocrinol Metab (1982) 1.65
Tubules are the major site of M-CSF production in experimental kidney disease: correlation with local macrophage proliferation. Kidney Int (2001) 1.60
Hypercalcaemia in rheumatoid arthritis: investigation of its causes and implications. Ann Rheum Dis (1979) 1.58
Effect of Toxoplasma gondii upon neophobic behaviour in wild brown rats, Rattus norvegicus. Parasitology (1994) 1.58
Intravesical pressure and the TUR syndrome. Anaesthesia (2001) 1.56
Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J (1997) 1.55
Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype. Am J Transplant (2010) 1.55
Retracted Altered calcitonin gene in a young patient with osteoporosis. BMJ (1989) 1.55
Modified method of spinal computed tomography for trabecular bone mineral measurements. J Comput Assist Tomogr (1986) 1.53
A biological assay for calcitonin. J Endocrinol (1965) 1.53
Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity. Clin Pharmacol Ther (1981) 1.52
Is baldness a risk factor for coronary artery disease? A review of the literature. J Clin Epidemiol (1990) 1.50
Polychlorinated biphenyl serum concentrations, lifestyle and time-to-pregnancy. Hum Reprod (2008) 1.48
Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens. Lancet (1981) 1.47
Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric (2011) 1.47
Cellular electrophysiological effects of hyperthermia on isolated guinea pig papillary muscle. Implications for catheter ablation. Circulation (1993) 1.46
A physiological role for calcitonin: protection of the maternal skeleton. Lancet (1979) 1.44
Hormone replacement therapy: where we stand in Europe. Eur Heart J (2001) 1.44
A gene cluster in Aspergillus nidulans with an internally located cis-acting regulatory region. Nature (1975) 1.44
The calcitonin-like sequence of the beta CGRP gene. FEBS Lett (1986) 1.43
Effect of calcitonin on gastrointestinal regulatory peptides in man. Clin Endocrinol (Oxf) (1985) 1.42
Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial. Fertil Steril (1995) 1.41
Non-invasive assessment of vascular function; paradoxical vascular response to intravenous glucose in coronary heart disease. Eur Heart J (2000) 1.39
Mitral valve prolapse. Anesthesiology (1996) 1.39
The teaching of immediate cardiac and trauma care to general practitioners in a skills-based outreach format: an assessment in terms of information gain. Med Educ (1999) 1.38
A phase II trial of the cyclin-dependent kinase inhibitor flavopiridol in patients with previously untreated stage IV non-small cell lung cancer. Clin Cancer Res (2001) 1.37
Chemistry, physiology, and therapeutic applications of calcitonin. Arthritis Rheum (1980) 1.34
Recurrence rates of neural tube defects in Dublin maternity hospitals. Ir Med J (1983) 1.32
Partial nucleotide sequence of human calcitonin precursor mRNA identifies flanking cryptic peptides. Nature (1982) 1.31
Thymic and parathyroid origin of calcitonin in man. Lancet (1968) 1.31
The incidence of biopsy-proven glomerulonephritis in Australia. Nephrol Dial Transplant (2001) 1.30
Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity. Am J Pathol (2001) 1.29
Time to end a conservative treatment for mild hyperparathyroidism. Br Med J (Clin Res Ed) (1988) 1.28
Infectious thromboembolic meningoencephalitis: literature review and occurrence in Alberta, 1969-71. Can Vet J (1973) 1.27
Radiological evidence of a dose-related response to long-term treatment of Paget's disease with human calcitonin. Br J Radiol (1974) 1.26
Effect of degenerative spinal and aortic calcification on bone density measurements in post-menopausal women: links between osteoporosis and cardiovascular disease? Eur J Clin Invest (1994) 1.24
1,25-dihydroxyvitamin-D-receptor in breast cancer cells. Lancet (1980) 1.22
Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms. Proc Natl Acad Sci U S A (1995) 1.21
Effect of PUVA on serum 25-OH vitamin D in psoriatics. Br Med J (1979) 1.21
A mutant of Asperigillus nidulans lacking NADP-linked glutamate dehydrogenase. Mol Gen Genet (1973) 1.21
A multicenter proficiency trial of gene amplification (PCR) for the detection of HIV-1. J Acquir Immune Defic Syndr (1991) 1.21
Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial--the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial. J Vasc Interv Radiol (2001) 1.20
Effect of calcitonin on vitamin D metabolism. Nature (1972) 1.19
Phosphaturic effect of thyrocalcitonin. Lancet (1966) 1.17
Effect of calcitonin gene-related peptide on contraction of striated muscle in the mouse. Neurosci Lett (1985) 1.17
Associations between bladder cancer risk factors and tumor stage and grade at diagnosis. Epidemiology (1994) 1.17
Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol (1998) 1.17
Risk of lymphoma subtypes after solid organ transplantation in the United States. Br J Cancer (2013) 1.17
A protocol for the videofluorographic swallowing study. Dysphagia (1993) 1.16
Interrelations of calcium-regulating hormones during normal pregnancy. Br Med J (Clin Res Ed) (1981) 1.16
Human calcitonin gene related peptide: a potent endogenous vasodilator in man. Clin Sci (Lond) (1986) 1.15